Cargando…
CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate
Ovarian cancer is a leading cause of death from gynecologic malignancies worldwide. Although CD83 is widely described as a solid marker for mature dendritic cells, emerging pieces of evidence indicate the expression of membrane protein CD83 by various tumor cells, including ovarian cancer cells. How...
Autores principales: | Batool, Aalia, Liu, Hao, Liu, Yi-Xun, Chen, Su-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465057/ https://www.ncbi.nlm.nih.gov/pubmed/32823589 http://dx.doi.org/10.3390/cancers12082269 |
Ejemplares similares
-
A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth
por: Batool, Aalia, et al.
Publicado: (2018) -
Dichotomy of the BSL phosphatase signaling spatially regulates MAPK components in stomatal fate determination
por: Guo, Xiaoyu, et al.
Publicado: (2022) -
Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
por: Li, Ziduo, et al.
Publicado: (2020) -
Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways
por: Rodriguez, Javier, et al.
Publicado: (2016) -
G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity
por: Müller, Anne, et al.
Publicado: (2013)